127 related articles for article (PubMed ID: 25283699)
1. Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations.
Chen F; Song S; Wang H; Zhang W; Lin C; Ma S; Ye T; Zhang L; Yang X; Qin X; Pan W
Int J Pharm; 2014 Dec; 476(1-2):232-40. PubMed ID: 25283699
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: design, optimization and in vitro and in vivo studies.
Zhang L; Chen F; Zheng J; Wang H; Qin X; Pan W
Drug Deliv; 2018 Nov; 25(1):690-702. PubMed ID: 29484910
[TBL] [Abstract][Full Text] [Related]
3. Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy--in vitro and in vivo studies.
Wang C; Liu J; Pan W; Wang X; Gao Q; Hou S
Int J Pharm; 2008 Mar; 351(1-2):219-26. PubMed ID: 18054185
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Pingyangmycin albumin microspheres on sclerostenosis of the rabbit central auricular arteries].
Gao QH; Zheng GJ; Wang XY; Zhou L; Dong JZ; Wang CM; Wen YM
Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):42-7. PubMed ID: 15747013
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of Pingyangmycin-loaded bovine serum albumin microspheres for embolization therapy.
Wang C; Liu J; Gao Q; Bi Y; Gan L; Wang X; Hou S
Int J Pharm; 2007 May; 336(2):361-6. PubMed ID: 17360133
[TBL] [Abstract][Full Text] [Related]
6. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels.
Gao Z; Ding P; Zhang L; Shi J; Yuan S; Wei J; Chen D
Int J Pharm; 2007 Jan; 328(1):57-64. PubMed ID: 16939703
[TBL] [Abstract][Full Text] [Related]
7. [Combined injection of pingyangmycin & dexamethasone for the treatment of maxillofacial and cervical venous malformations].
Zhai J; Zhai XD
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):168-71. PubMed ID: 22870701
[TBL] [Abstract][Full Text] [Related]
8. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.
Bai N; Chen YZ; Fu YJ; Wu P; Zhang WN
J Clin Pharm Ther; 2014 Oct; 39(5):521-6. PubMed ID: 24924412
[TBL] [Abstract][Full Text] [Related]
9. [Embolization and degradation of arteries in vivo by pingyangmycin albumin microspheres].
Wang LL; Gao QH; Zheng GJ; Wang XY; Zhou L; Wang CM; Wen YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):279-83. PubMed ID: 19462907
[TBL] [Abstract][Full Text] [Related]
10. Application of microdialysis to study the in vivo release of pingyangmycin from in situ gels in rabbits.
Gao ZB; Ding PT; Zhang L; Yuan ZT; Shi J; Wei J; Chen DW
Biomed Chromatogr; 2006 Nov; 20(11):1223-8. PubMed ID: 16799932
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of lidocaine with pingyangmycin for treatment of venous malformation using a mouse spleen model.
Bai N; Chen YZ; Mao KP; Fu Y; Lin Q; Xue Y
Int J Clin Exp Pathol; 2014; 7(5):2324-36. PubMed ID: 24966943
[TBL] [Abstract][Full Text] [Related]
12. [Electrochemical therapy combined with pingyangmycin injection in the management of high-return flow venous malformation].
Wei JJ; Li QJ; Xue L; Jin ZL; Yuan WL; Wang XK
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Mar; 47(3):160-3. PubMed ID: 22800669
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells].
Kong WD; Li YH; Zeng QL; Chen Y; He XF
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):830-2, 836. PubMed ID: 12919911
[TBL] [Abstract][Full Text] [Related]
14. Pingyangmycin-regulated expressions of adhesion molecules in human venous malformation endothelial cells.
Jia Y; Jia J; Zhao Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):760-766. PubMed ID: 23073810
[TBL] [Abstract][Full Text] [Related]
15. [Pingyangmycin gelatin microspheres: preparation and drug release characteristics].
Wu H; Wu D; Yu K; Feng X; Yao Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):646-9. PubMed ID: 14716867
[TBL] [Abstract][Full Text] [Related]
16. [An experirmental study on the preparation and drug sustained release characteristics of Pingyangmycin Albumin Microspheres].
Gao QH; Zheng GJ; Wang CG; Zhou L; Wen YM; Wang CM; Hou SX
Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Feb; 23(1):69-71. PubMed ID: 15804028
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
[TBL] [Abstract][Full Text] [Related]
18. [Effect of antibody-targeted chemotherapy with pingyangmycin on prostate cancer cells in vitro].
Chen WZ; Zhang Y; Liang CS; Xie Y; Wen QQ; Gao X
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):406-8. PubMed ID: 18359702
[TBL] [Abstract][Full Text] [Related]
19. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-kinase/Akt pathway is involved in pingyangmycin‑induced growth inhibition, apoptosis and reduction of invasive potential in EOMA mouse hemangioendothelioma cells.
Peng LX; Zhao P; Zhao HS; Pan E; Yang BB; Li Q
Mol Med Rep; 2015 Dec; 12(6):8275-81. PubMed ID: 26498320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
